Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference
Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) announced that Robert Cohen, Interim CEO, and Stephanie Morley, President and CMO, will present at the H.C. Wainwright Virtual Global Investment Conference on September 14, 2020, at 4:00 pm ET. The presentation slides will be available on the company's website on the morning of the event. Zomedica focuses on creating innovative veterinary diagnostic products for companion animals, addressing unmet needs in veterinary care to enhance productivity and revenue for clinical veterinarians.
- Presentation at H.C. Wainwright Virtual Global Investment Conference demonstrates company transparency and investor engagement.
- Focus on point-of-care diagnostics highlights innovative approach to veterinary health.
- Dependence on events like the conference for investor communication may indicate a lack of regular updates.
ANN ARBOR, Mich., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), a veterinary health company creating point-of-care diagnostics products for companion animals, announced today that Robert Cohen, Interim Chief Executive Officer, and Stephanie Morley, President and Chief Medical Officer, will present at the upcoming H.C. Wainwright Virtual Global Investment Conference. The presentation is scheduled for September 14, 2020 at 4:00 pm ET.
The slides to be presented by Mr. Cohen and Dr. Morley will be accessible through the Investors section of the Company's website at www.zomedica.com the morning of the presentation.
About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include innovative diagnostics and therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to provide veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
- Email Alerts: http://investors.zomedica.com
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://www.facebook.com/zomedica/
- Twitter: https://twitter.com/zomedica
Investor Relations Contact:
PCG Advisory Group
Kirin Smith, COO
ksmith@pcgadvisory.com
+1 646.863.6519
www.pcgadvisory.com
Media Contact:
Meredith Newman
mnewman@zomedica.com
+1 734.369.2555 ext. 119
FAQ
What is Zomedica Pharmaceuticals planning to present at the conference on September 14, 2020?
Who will represent Zomedica Pharmaceuticals at the H.C. Wainwright Virtual Global Investment Conference?
Where can I find the presentation slides from Zomedica's conference presentation?
